CCND1 amplification and cyclin D1 overexpression in HNSCCs have been reported to be associated with a high rate of relapse, lymph node metastasis and shorter patient survival [194]. The gene discussed is CCND1; the disease is metastatic malignant neoplasm in the lymph nodes.